The present invention relates to methods for prevention and treatment of
bone-related disorders and calcium homeostasis related syndromes using a
GLP-2 molecule or GLP-2 activator either alone or in combination with
another therapeutic. The present invention also encompasses methods of
diagnosing or monitoring the progression of a disorder. The invention
also encompasses methods of monitoring the effectiveness of treatment of
the invention.
